Dimension Therapeutics, Inc. Operating Income
Dimension Therapeutics, Inc. reported Operating Income of -$16.97 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2017-11-06
- Dimension Therapeutics, Inc. operating income (loss) for the quarter ending 2017-09-30 was -$16.97M.
- Dimension Therapeutics, Inc. operating income (loss) for the quarter ending 2017-06-30 was -$12.33M.
- Dimension Therapeutics, Inc. operating income (loss) for the quarter ending 2017-03-31 was -$13.53M.
- Dimension Therapeutics, Inc. operating income (loss) for the quarter ending 2016-12-31 was -$13.07M.
- Dimension Therapeutics, Inc. operating income (loss) for fiscal 2016 was -$49.05M.
- Dimension Therapeutics, Inc. operating income (loss) for fiscal 2015 was -$34.97M.
- Dimension Therapeutics, Inc. operating income (loss) for fiscal 2014 was -$12.95M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$16.97M 10-Q · filed 2017-11-06 | -$29.30M derived: sum of 2 quarters · filed 2017-11-06 | -$42.83M 10-Q · filed 2017-11-06 | -$55.90M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-06-30 | -$12.33M 10-Q · filed 2017-08-08 | -$25.86M 10-Q · filed 2017-08-08 | -$38.92M derived: sum of 3 quarters · filed 2017-08-08 | -$53.26M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-03-31 | -$13.53M 10-Q · filed 2017-05-10 | -$26.59M derived: sum of 2 quarters · filed 2017-05-10 | -$40.93M derived: sum of 3 quarters · filed 2017-11-06 | -$53.04M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-12-31 | -$13.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$27.41M derived: sum of 2 quarters · filed 2017-11-06 | -$39.51M derived: sum of 3 quarters · filed 2017-11-06 | -$49.05M 10-K · filed 2017-03-09 |
| 2016-09-30 | -$14.34M 10-Q · filed 2017-11-06 | -$26.44M derived: sum of 2 quarters · filed 2017-11-06 | -$35.98M 10-Q · filed 2017-11-06 | -$44.99M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | -$12.11M 10-Q · filed 2017-08-08 | -$21.64M 10-Q · filed 2017-08-08 | -$30.65M derived: sum of 3 quarters · filed 2017-08-08 | -$41.30M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | -$9.54M 10-Q · filed 2017-05-10 | -$18.55M derived: sum of 2 quarters · filed 2017-05-10 | -$29.19M derived: sum of 3 quarters · filed 2017-05-10 | -$39.14M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | -$9.01M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$19.65M derived: sum of 2 quarters · filed 2017-03-09 | -$29.60M derived: sum of 3 quarters · filed 2017-03-09 | -$34.97M 10-K · filed 2017-03-09 |
| 2015-09-30 | -$10.64M 10-Q · filed 2016-11-10 | -$20.59M derived: sum of 2 quarters · filed 2016-11-10 | -$25.96M 10-Q · filed 2016-11-10 | -$30.56M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | -$9.95M 10-Q · filed 2016-08-11 | -$15.31M 10-Q · filed 2016-08-11 | -$19.91M derived: sum of 3 quarters · filed 2017-03-09 | -$22.40M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | -$5.37M 10-Q · filed 2016-05-12 | -$9.97M derived: sum of 2 quarters · filed 2017-03-09 | -$12.45M derived: sum of 3 quarters · filed 2017-03-09 | |
| 2014-12-31 | -$4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$7.08M derived: sum of 2 quarters · filed 2017-03-09 | -$12.95M 10-K · filed 2017-03-09 | |
| 2014-09-30 | -$2.48M 10-Q · filed 2015-12-04 | -$8.35M 10-Q · filed 2015-12-04 | ||
| 2013-12-31 | -$3.17M 10-K · filed 2016-03-24 |